Literature DB >> 8373908

Erythromycin increases gastric antral motility in human premature infants.

T Tomomasa1, M Miyazaki, T Koizumi, T Kuroume.   

Abstract

The aim of this study was to determine if erythromycin (EM), which is a potent motilin agonist, alters gastrointestinal motility in premature infants. Six infants who were born after 23-30 weeks gestation and weighed 825-1,408 g at birth were studied when 6-31 days old. Intraluminal pressure changes within the gastric antrum and proximal duodenum were recorded. We infused EM 0.75 mg/kg intravenously for 15 min and we compared gastric and duodenal contractions for 30 min between before and after the initiation of EM infusion. In these preterm infants the migrating complex was not present, and was not induced by EM. However, in all 6 infants EM increased nonpropagating antral clusters of contractions (p < 0.05). The antral motility index increased 4-fold (p < 0.05). We concluded that human premature infants have functioning motilin receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373908     DOI: 10.1159/000243954

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  8 in total

1.  Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.

Authors:  P C Ng; K W So; K S Fung; C H Lee; T F Fok; E Wong; W Wong; K L Cheung; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

2.  Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial.

Authors:  A Lander; R Redkar; G Nicholls; A Lawson; S R Choudhury; J J Corkery; P Gornall; R G Buick; I W Booth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

3.  Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial.

Authors:  B J Stenson; L Middlemist; A J Lyon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

Review 4.  Macrolide antibiotics in paediatric infectious diseases.

Authors:  D R Guay
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 5.  Erythromycin as a prokinetic agent in preterm neonates: a systematic review.

Authors:  S Patole; S Rao; D Doherty
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-17       Impact factor: 5.747

Review 6.  Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature.

Authors:  Emma M Tillman; Keaton S Smetana; Likeselam Bantu; Merrion G Buckley
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Mar-Apr

7.  Influence of high-dose oral erythromycin on feeding intolerance in preterm neonates: A randomized controlled trial.

Authors:  Maryam Saboute; Ali Mazouri; Fatemeh NaimiDehnavi; Nasrin Khalesi; Zahra Farahani
Journal:  Med J Islam Repub Iran       Date:  2018-02-09

8.  High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.

Authors:  Pak C Ng; Cheuk H Lee; Samuel P S Wong; Hugh S Lam; Flora Y B Liu; King W So; Cheuk Y Lee; Tai F Fok
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.